A- A A+

Pregabalin (Lyrica): reports of severe respiratory depression 

Pregabalin has been associated with infrequent reports of severe respiratory depression, including some cases without the presence of concomitant opioid medicines. Patients with compromised respiratory function, respiratory or neurological disease, renal impairment; those using concomitant central nervous system (CNS) depressants; and people older than 65 years might be at higher risk of experiencing these events and adjustments in dose or dosing regimen may be necessary. (gov.uk, Medicines and Healthcare products Regulatory Agency, UK, 18.02.2021)

https://www.gov.uk/drug-safety-update/pregabalin-lyrica-reports-of-severe-respiratory-depression